Generic Name: Saxagliptin
Brand Name: Onglyza
Manufacturer: Bristol-Myers Squibb / AstraZeneca Canada Inc.
Indications: Diabetes mellitus (Type 2)
Submission Type: Resubmission
Project Status: Withdrawn
Saxagliptin
Last Updated: May 28, 2012
Result type: Reports
Project Number: SR0280
Product Line: Common Drug Review